Deaths Associated with Human Adenovirus-14p1 Infections, Europe, 2009–2010Michael J. Carr, William W. Hall, Adriana E. Kajon et al.|Emerging infectious diseases|2011Cited by 75
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021Esther Kissling, Josie Murray, Sylvie Belhillil et al.|Eurosurveillance|2021Cited by 55
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre studyEsther Kissling, Francisco Pozo, Iván Martínez‐Baz et al.|Influenza and Other Respiratory Viruses|2022Cited by 45
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021Esther Kissling, Mariëtte Hooiveld, Iván Martínez‐Baz et al.|Eurosurveillance|2022Cited by 27
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre study analysis by age-group, vaccine brand and time since vaccination, I-MOVE-COVID-19 and ECDC networks, July–August 2021Esther Kissling, Marta Valenciano, Mariëtte Hooiveld et al.|Unknown|2021Cited by 2